88636128 - ACIU

Information

  • Trademark
  • 88636128
  • Serial Number
    88636128
  • Registration Number
    6909260
  • Filing Date
    September 30, 2019
    5 years ago
  • Registration Date
    November 29, 2022
    2 years ago
  • Transaction Date
    November 29, 2022
    2 years ago
  • Status Date
    November 29, 2022
    2 years ago
  • Published for Opposition Date
    September 14, 2021
    3 years ago
  • Location Date
    November 29, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KUMIS, SCOTT N
  • Attorney Docket Number
    029140-1
    Attorney Name
    Kristina Montanaro Schrader
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
4000
Mark Identification
ACIU
Case File Statements
  • GS0051: Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
  • GS0011: Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use
  • GS0421: Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering
Case File Event Statements
  • 11/29/2022 - 2 years ago
    36 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/29/2022 - 2 years ago
    35 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/26/2022 - 2 years ago
    34 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 10/10/2022 - 2 years ago
    33 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 10/26/2022 - 2 years ago
    32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/10/2022 - 2 years ago
    31 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 5/11/2022 - 2 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/9/2022 - 2 years ago
    29 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/9/2022 - 2 years ago
    28 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/9/2022 - 2 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/27/2022 - 2 years ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/27/2022 - 2 years ago
    25 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/27/2022 - 2 years ago
    24 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/9/2021 - 3 years ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/14/2021 - 3 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/14/2021 - 3 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/26/2021 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/26/2021 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/26/2021 - 3 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/10/2021 - 3 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/6/2021 - 3 years ago
    14 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 5/13/2021 - 3 years ago
    13 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 7/29/2020 - 4 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 7/29/2020 - 4 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 7/29/2020 - 4 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 7/3/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/2/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/2/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/7/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/7/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/7/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/3/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/3/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/3/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP